The overexpression of the ErbB-2 gene, which encodes HER2 oncoprotein exists in 20-25% of breast cancers, which is associated with poor prognosis, the higher chance of metastasis, and relapse (Venturutti et al., 2016). Here, ERBB2 is linked to breast carcinoma.